Cargando…
Half Dose Once-Daily Pemafibrate Effectively Improved Hypertriglyceridemia in Real Practice
BACKGROUND: Hyperlipidemia is a worldwide problem related to cardiovascular disease (CVD) and sudden death. Low-density lipoprotein cholesterol (LDL-C) has been treated well by the use of statins, but hypertriglyceridemia was not the case. Previous fibrates have been shown a certain effect of preven...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785276/ https://www.ncbi.nlm.nih.gov/pubmed/31636783 http://dx.doi.org/10.14740/jocmr3949 |